Avedro Announces Pricing of Initial Public Offering

HealthQuest portfolio company Avedro, Inc. (Nasdaq: AVDR), a leading commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $14.00 per share, for total gross proceeds of $70.0 million.

Read More
Randy Scott
Venus Heal™ Receives FDA Clearance

Venus Concept announces the launch of its latest device, Venus Heal, which is now cleared in the U.S. to treat soft tissue injuries and conditions. Venus Heal is intended to relieve pain, improve blood circulation, and increase range of motion through the relief of muscle spasm.

Read More
Randy Scott
Trice Medical Acquires SegWAY Orthopaedics

Trice Medical announced that it is acquiring S.E.GWAY Orthopaedics (SegWAY), a leader in solutions for minimally invasive orthopedic procedures. SegWAY is best known for its Endoscopic Carpal Tunnel Release (ECTR), a device that supports minimally invasive carpal tunnel surgeries.

Read More
Randy Scott
HealthQuest Co-Leads Investment into Etairos

HealthQuest has made an equity investment in Etairos Health. Etairos an in-home senior care company providing non-skilled and skilled care primarily to the senior population. Etairos acquires selected home care agencies that fit well with its care philosophy and business model, integrates and then expands them, allowing for the creation of a leading regional home care provider. 

Read More
Randy Scott
Biotheranostics’ Breast Cancer Index® Recently Recognized in Two National Clinical Practice Guidelines

Clinical Practice Guidelines Recognize Breast Cancer Index Clinical Utility Spans the Treatment Continuum for Patients with Early-Stage Estrogen Receptor Positive (ER+) Disease

Breast Cancer Index Endorsed in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Breast Cancer and American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Focused Update

Read More
Randy Scott
HealthQuest leads $26.5 million investment into BioIQ

HealthQuest led a $26.5 million investment into BioIQ, the leading platform for orchestrating health testing programs and biometric screening events across multiple vendors.  Additionally, BioIQ utilizes multi-channel communication tools for engaging and motivating participants.  HealthQuest was joined in this investment by Arboretum Ventures and select insiders. 

Read More
Randy Scott
HealthQuest participates in follow-on financing for Venus Concept

HealthQuest Capital, EW Healthcare partners and Madryn Asset Management invested an additional $7 million in Venus Concept concurrent with the completion of the acquisition of NeoGraft.  NeoGraft is an industry leader in the area of hair restoration technologies.  Venus Concept's industry first and only subscription-based business model, combined with its global reach in over 60 countries and 27 direct global offices, will create a significant opportunity to expand the overall combined businesses of both NeoGraft and Venus Concept.

Read More
Randy Scott
HealthQuest leads $20 million investment into Springbuk

HealthQuest led a $20 million investment into Springbuk, the leading employer-facing health intelligence software.  HealthQuest was joined in this investment by Echo Health Ventures and Lewis & Clark Ventures.

Springbuk was founded in 2015 by Rod Reasen and Phil Daniels, co-founders of the Healthiest Employers awards program, with the mission to empower employers to lower their healthcare costs by harnessing their health data. Today, over 1,000 employers use Springbuk’s software to glean actionable insights to improve their population’s health.

Read More
Randy Scott